GO:1901258 positive regulation of macrophage colony-stimulating factor production: Cytokine Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901258 describes any biological process that activates or increases the production of macrophage colony-stimulating factor (M-CSF/CSF1), a key cytokine controlling monocyte/macrophage lineage survival, proliferation and differentiation.
• M-CSF production is regulated at the level of transcription, mRNA stability and secretion, and can be modulated by neuropeptides, transcription factors and inflammatory signals.
• Positive regulation of M-CSF production is important in myelopoiesis, osteoclastogenesis, granulosa cell biology and immune cell recruitment.
• Dysregulated M-CSF production contributes to myocardial ischemia/reperfusion injury, inflammatory disease and tumor-associated macrophage biology.
• Key genes/proteins implicated in this process include CSF1, PEBP2/AML1-related transcription factors, THOC5, KLF4 and Dectin-1.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect causal roles of candidate regulators of M-CSF production.
Description
Macrophage colony-stimulating factor (M-CSF, also known as CSF1) is a hematopoietic cytokine that drives the survival, proliferation and differentiation of monocytes and macrophages. The Gene Ontology term GO:1901258, positive regulation of macrophage colony-stimulating factor production, captures any process that activates or increases the frequency, rate or extent of M-CSF production. This term is of broad interest because M-CSF is not only a myelopoietic growth factor but also a mediator of innate immune responses, osteoclast biology and tissue remodeling. Understanding how M-CSF production is positively regulated provides mechanistic insight into inflammatory diseases, bone disorders and cancer. At the cellular level, positive regulation of M-CSF production can occur through transcriptional activation of the CSF1 gene, stabilization of CSF1 mRNA, enhanced translation or increased secretion. Neuropeptides such as neurotensin have been shown to modulate M-CSF-stimulated myelopoiesis, indicating that neural and immune signals can converge on this pathway. Transcription factors of the PEBP2/AML1 family can positively or negatively regulate the GM-CSF promoter, illustrating the complexity of cytokine gene control. More recently, THOC5 has been implicated in human osteoclastogenesis, a process dependent on M-CSF signaling. For researchers, GO:1901258 offers a framework to annotate and interrogate genes that control M-CSF levels. Because M-CSF is central to macrophage biology, perturbations in its positive regulation can alter host defense, tissue repair and tumor microenvironment. This article reviews the definition, mechanisms, key genes, disease links and experimental models relevant to GO:1901258, with a focus on CRISPR-based approaches for functional validation.
positive regulation of macrophage colony-stimulating factor production At A Glance
| GO ID | GO:1901258 |
|---|---|
| GO term | positive regulation of macrophage colony-stimulating factor production |
| Ontology | biological_process |
| Synonym | activation of M-CSF production; positive regulation of M-CSF production; upregulation of macrophage colony-stimulating factor production |
| Major function | Increases the production of M-CSF/CSF1, a cytokine that supports monocyte/macrophage survival, proliferation and differentiation |
| Related cytokine | M-CSF (CSF1), distinct from GM-CSF (CSF2) |
| Key cell types | Monocytes, macrophages, osteoclast precursors, granulosa cells |
| Disease relevance | Myocardial ischemia/reperfusion injury, inflammatory disease, cancer |
What Is GO:1901258?
GO:1901258 is a biological process term defined as any process that activates or increases the frequency, rate or extent of macrophage colony-stimulating factor production. In other words, it covers the upstream signals, transcription factors, RNA-binding proteins and secretory pathways that elevate the amount of M-CSF (CSF1) produced by a cell. It is a positive regulatory term, meaning it is specifically about upregulation rather than baseline or inhibitory control of M-CSF production.
Why Is positive regulation of macrophage colony-stimulating factor production Important in Cell Biology?
Positive regulation of M-CSF production is important because M-CSF is a master cytokine for the mononuclear phagocyte system. It controls the development and function of macrophages, which are central to innate immunity, tissue homeostasis and pathology. Dysregulated M-CSF production has been linked to myocardial ischemia/reperfusion injury, where Dectin-1 signaling influences macrophage polarization and neutrophil infiltration. In bone, M-CSF is essential for osteoclastogenesis, and factors such as THOC5 regulate this process in humans. In the ovary, M-CSF produced by granulosa cells influences follicular development. Thus, understanding GO:1901258 has implications for immunology, hematology, bone biology and reproductive biology.
• M-CSF is required for monocyte and macrophage survival, proliferation and differentiation.
• Positive regulation of M-CSF production supports myelopoiesis in vitro and in vivo.
• M-CSF is a key factor for osteoclastogenesis, linking this GO term to bone remodeling.
• Granulosa cells produce M-CSF, implicating this process in ovarian function.
• Dectin-1 signaling modulates macrophage polarization and neutrophil infiltration in myocardial ischemia/reperfusion injury, a context where M-CSF regulation is relevant.
• Transcription factors such as PEBP2/AML1 can regulate cytokine promoters, providing a mechanism for positive regulation.
• THOC5 regulates human osteoclastogenesis, a process dependent on M-CSF.
• KLF4 controls homeostatic CD4 T cells via pDC-like cells, a pathway that may intersect with M-CSF biology.
• Chemokines such as TARC and MDC recruit CCR4-bearing Th2 cells, indirectly influencing macrophage-derived signals.
• GM-CSF, a related cytokine, has direct effects on adaptive immunogenesis, highlighting the broader colony-stimulating factor network.
What Happens During positive regulation of macrophage colony-stimulating factor production?
Initiation by extracellular signals
In simple terms: A cell receives a signal from outside that tells it to make more M-CSF.
Positive regulation of M-CSF production can be initiated by extracellular cues such as neuropeptides, cytokines or pathogen-derived molecules. For example, neurotensin has been shown to regulate M-CSF-stimulated myelopoiesis, indicating that neuropeptide signals can modulate this pathway. In myocardial ischemia/reperfusion injury, Dectin-1 contributes to injury by regulating macrophage polarization and neutrophil infiltration, a process in which M-CSF production may be positively regulated. These signals converge on intracellular signaling cascades that ultimately increase CSF1 gene expression or M-CSF secretion.
Transcriptional activation of CSF1
In simple terms: The cell switches on the gene that codes for M-CSF.
Transcriptional activation of the CSF1 gene is a central step in positive regulation of M-CSF production. Transcription factors such as PEBP2/AML1-related proteins can positively or negatively regulate cytokine promoter activity, as shown for the GM-CSF promoter. Although the exact transcription factors controlling CSF1 in all contexts are not fully defined, the principle that cytokine gene promoters are subject to positive regulation by sequence-specific DNA-binding proteins is well established. In osteoclastogenesis, THOC5 regulates human osteoclastogenesis, potentially influencing M-CSF-dependent gene expression programs.
Post-transcriptional and secretory control
In simple terms: After the gene is switched on, the cell can still adjust how much M-CSF protein is made and released.
Positive regulation of M-CSF production also occurs post-transcriptionally, through mRNA stability, translation efficiency and secretory pathway activity. RNA-binding proteins and splicing factors such as THOC5 can influence the fate of cytokine mRNAs. In granulosa cells, M-CSF production is regulated in a cell-type-specific manner, suggesting that post-transcriptional mechanisms may contribute to the overall output. The secreted M-CSF then acts on target cells bearing the CSF1 receptor, promoting monocyte/macrophage survival and differentiation.
Feedback and integration with immune networks
In simple terms: The amount of M-CSF made is adjusted by feedback from the immune system.
Positive regulation of M-CSF production is integrated with broader immune networks. For instance, GM-CSF has direct effects on adaptive immunogenesis, and the two colony-stimulating factors can influence overlapping cell populations. Chemokines such as TARC and MDC recruit CCR4-bearing Th2 cells toward antigen-presenting cells, shaping the immune microenvironment in which M-CSF acts. KLF4 controls homeostatic CD4 T cells via pDC-like cells, illustrating how transcription factors can modulate immune cell circuits that may intersect with M-CSF biology. These feedback loops ensure that M-CSF production is tuned to the needs of the tissue.
Key Genes Involved in GO:1901258 positive regulation of macrophage colony-stimulating factor production
The following genes and proteins have been experimentally linked to processes that positively regulate M-CSF production or to M-CSF-dependent biology, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSF1 | Encodes macrophage colony-stimulating factor (M-CSF) | Core cytokine whose production is the subject of GO:1901258 |
| CSF1R | Receptor for M-CSF | Mediates M-CSF signaling in monocytes/macrophages |
| PEBP2/AML1 | Transcription factor regulating cytokine promoters | Can positively or negatively regulate GM-CSF promoter activity |
| THOC5 | RNA-binding protein involved in mRNA export | Regulates human osteoclastogenesis, a process dependent on M-CSF |
| KLF4 | Transcription factor controlling pDC-like cells | Controls homeostatic CD4 T cells, potentially intersecting with M-CSF biology |
| Dectin-1 | Pattern recognition receptor | Contributes to myocardial ischemia/reperfusion injury by regulating macrophage polarization |
| CSF2 | Encodes GM-CSF | Related colony-stimulating factor with direct effects on adaptive immunogenesis |
| CCR4 | Chemokine receptor | Recruits Th2 cells toward antigen-presenting cells, shaping the immune microenvironment |
| TARC/CCL17 | CC chemokine | Selectively recruits CCR4-bearing Th2 cells |
| MDC/CCL22 | CC chemokine | Selectively recruits CCR4-bearing Th2 cells |
| Neurotensin | Neuropeptide | Regulates M-CSF-stimulated in vitro myelopoiesis |
| Granulosa cell factors | Ovarian cell-derived regulators | M-CSF plays a role in human granulosa cells |
| Osteoclast precursors | Monocyte lineage cells | THOC5 regulates human osteoclastogenesis |
| Macrophages | M-CSF target cells | Central to Dectin-1-mediated injury and repair |
| Neutrophils | Inflammatory cells | Infiltration regulated by Dectin-1 in myocardial injury |
| pDC-like cells | Pre-DC2 population | Require KLF4 to control homeostatic CD4 T cells |
| Th2 cells | T helper subset | Recruited by TARC/MDC via CCR4 |
| Antigen-presenting cells | Immune cells | Produce chemokines that recruit Th2 cells |
How Is positive regulation of macrophage colony-stimulating factor production Regulated?
Positive regulation of M-CSF production is controlled at multiple levels. Transcription factors such as PEBP2/AML1-related proteins can activate or repress cytokine gene promoters, providing a direct transcriptional mechanism. RNA-binding proteins like THOC5 influence mRNA processing and export, which can affect the amount of M-CSF produced. Neuropeptides such as neurotensin modulate M-CSF-stimulated myelopoiesis, indicating neuroendocrine input. In the immune microenvironment, chemokines and their receptors (e.g., TARC/MDC-CCR4 axis) shape the cellular context in which M-CSF is produced. KLF4-dependent control of pDC-like cells further illustrates how transcription factors can regulate immune cell circuits that may feed back on M-CSF production. Together, these layers ensure that M-CSF production is tightly regulated in response to physiological and pathological cues.
positive regulation of macrophage colony-stimulating factor production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Dectin-1 (CLEC7A) | Myocardial ischemia/reperfusion injury | Knockout mouse or CRISPR KO in macrophage cell lines |
| THOC5 | Osteoclastogenesis and bone remodeling | CRISPR KO in human osteoclast precursor cells |
| CSF1 | Myelopoiesis and macrophage differentiation | Overexpression or knock-in reporter in myeloid cell lines |
| KLF4 | Homeostatic CD4 T cell control | Conditional KO in pDC-like cells |
| PEBP2/AML1 | Cytokine promoter regulation | Promoter-reporter assays with point mutations |
Myocardial ischemia/reperfusion injury
Dectin-1 contributes to myocardial ischemia/reperfusion injury by regulating macrophage polarization and neutrophil infiltration. Since M-CSF is a key driver of macrophage biology, positive regulation of M-CSF production may influence the inflammatory response in this setting. Targeting this pathway could modulate injury severity.
Bone disorders and osteoclastogenesis
M-CSF is essential for osteoclast differentiation, and THOC5 regulates human osteoclastogenesis. Dysregulation of positive regulation of M-CSF production could therefore contribute to bone loss or abnormal bone remodeling. Experimental models of osteoclastogenesis are useful to study this link.
Ovarian function and reproductive biology
M-CSF plays a role in human granulosa cells, suggesting that positive regulation of its production is relevant to ovarian physiology. Altered M-CSF levels may affect follicular development and corpus luteum function. Granulosa cell culture models can be used to dissect these mechanisms.
Inflammatory and immune-mediated diseases
GM-CSF, a related cytokine, has direct effects on adaptive immunogenesis, and chemokines such as TARC and MDC recruit Th2 cells, shaping immune responses. KLF4 controls homeostatic CD4 T cells via pDC-like cells. These pathways illustrate how positive regulation of M-CSF production may intersect with inflammatory and autoimmune conditions.
From positive regulation of macrophage colony-stimulating factor production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene positively regulate M-CSF production? | CRISPR knockout in macrophage-like cells followed by M-CSF ELISA |
| Does a specific point mutation alter transcription factor activity on the CSF1 promoter? | Point-mutation knock-in via CRISPR in reporter cell lines |
| Does overexpression of a candidate gene increase M-CSF secretion? | CRISPR activation or cDNA overexpression in granulosa or myeloid cells |
| Does a tagged version of a regulator localize to the CSF1 promoter? | Tagged knock-in (e.g., GFP or HA) followed by ChIP or imaging |
| Does loss of an RNA-binding protein affect M-CSF mRNA stability? | CRISPR KO of THOC5 or related factors in osteoclast precursors |
| Does modulation of Dectin-1 signaling alter M-CSF production in injury? | In vivo KO or knock-in in myocardial ischemia/reperfusion models |
How to Study the positive regulation of macrophage colony-stimulating factor production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Luciferase reporter assay | Transcriptional activity of CSF1 promoter | Testing transcription factor effects |
| RNA-seq | Global mRNA changes including CSF1 | Identifying pathways that regulate M-CSF production |
| qPCR | CSF1 mRNA levels | Validating changes in M-CSF expression |
| ELISA | Secreted M-CSF protein | Quantifying M-CSF production in cell culture |
| Western blot | Intracellular M-CSF protein | Confirming protein-level changes |
| Macrophage differentiation assay | Monocyte-to-macrophage differentiation | Functional readout of M-CSF activity |
| Osteoclastogenesis assay | Osteoclast formation from precursors | Studying THOC5 and M-CSF-dependent bone biology |
| Chemotaxis assay | Th2 cell migration | Modeling CCR4-mediated recruitment |
Transcriptional reporter assays
Reporter assays using the CSF1 promoter or cytokine promoters can measure positive regulation of M-CSF production at the transcriptional level. PEBP2/AML1-related factors have been studied using such assays to show positive and negative regulation of the GM-CSF promoter. These methods are useful for dissecting cis-regulatory elements and transcription factor binding sites.
RNA-level analysis (RNA-seq, qPCR)
RNA-seq and qPCR can quantify CSF1 mRNA levels under conditions that positively regulate M-CSF production. THOC5, an RNA-binding protein, regulates osteoclastogenesis and may affect cytokine mRNA processing. These methods help distinguish transcriptional from post-transcriptional regulation.
Protein-level analysis (ELISA, Western blot)
ELISA and Western blot measure secreted and intracellular M-CSF protein. In granulosa cells, M-CSF production has been assessed to understand its role in ovarian function. These methods are essential to confirm that changes in mRNA translate into changes in protein output.
Functional immune assays
Macrophage differentiation, osteoclastogenesis and T cell polarization assays can link positive regulation of M-CSF production to downstream biology. Dectin-1-mediated macrophage polarization and neutrophil infiltration in myocardial injury is one example. THOC5 regulation of osteoclastogenesis is another. Chemokine-mediated Th2 recruitment can also be modeled.
How CRISPR Can Be Used to Study GO:1901258 positive regulation of macrophage colony-stimulating factor production
Knockout
CRISPR knockout of candidate genes such as Dectin-1, THOC5 or KLF4 can test whether they are required for positive regulation of M-CSF production. For example, Dectin-1 knockout models have been used to study macrophage polarization and neutrophil infiltration in myocardial ischemia/reperfusion injury. THOC5 knockout can reveal its role in osteoclastogenesis. KLF4 knockout in pDC-like cells affects homeostatic CD4 T cells.
Point Mutation
Point mutations can be introduced into transcription factor binding sites in the CSF1 promoter or into coding regions of regulators. PEBP2/AML1-related factors regulate cytokine promoters, and point mutations can dissect which residues or DNA elements are critical. Such models help distinguish loss-of-function from gain-of-function mechanisms.
Knock-in
Knock-in of reporter genes (e.g., luciferase, GFP) into the CSF1 locus allows real-time monitoring of M-CSF production. Tagged knock-in of regulators can enable ChIP or imaging studies to localize them at the CSF1 promoter. Knock-in of disease-associated variants can model how genetic changes affect M-CSF regulation.
Overexpression
CRISPR activation or cDNA overexpression can test whether a candidate gene is sufficient to increase M-CSF production. Overexpression of transcription factors like PEBP2/AML1 can enhance cytokine promoter activity. In granulosa cells, overexpression studies can clarify the role of M-CSF in ovarian function. Overexpression of chemokines or their receptors can model immune microenvironment changes.
How EDITGENE Supports positive regulation of macrophage colony-stimulating factor production Research
Researchers studying positive regulation of macrophage colony-stimulating factor production-related genes often need to determine whether a candidate gene is causally involved in M-CSF regulation or merely correlated with it. CRISPR-based models provide the gold standard for such causal inference, enabling precise knockout, point mutation, knock-in and overexpression in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of macrophage colony-stimulating factor production research.
Frequently Asked Questions About positive regulation of macrophage colony-stimulating factor production
What is GO:1901258?
GO:1901258 is the Gene Ontology term for positive regulation of macrophage colony-stimulating factor production, describing any process that increases the production of M-CSF (CSF1).
What is macrophage colony-stimulating factor?
Macrophage colony-stimulating factor (M-CSF or CSF1) is a cytokine that promotes the survival, proliferation and differentiation of monocytes and macrophages.
What genes are involved in positive regulation of M-CSF production?
Genes such as CSF1, CSF1R, PEBP2/AML1, THOC5, KLF4 and Dectin-1 have been linked to M-CSF biology or its regulation.
How is M-CSF production regulated?
M-CSF production is regulated at transcriptional, post-transcriptional and secretory levels by transcription factors, RNA-binding proteins and extracellular signals.
What diseases are associated with M-CSF dysregulation?
M-CSF dysregulation has been implicated in myocardial ischemia/reperfusion injury, bone disorders, ovarian dysfunction and inflammatory diseases.
What cell types produce M-CSF?
M-CSF is produced by various cell types including macrophages, granulosa cells and stromal cells.
How can I study positive regulation of M-CSF production?
You can use CRISPR knockout, reporter assays, RNA-seq, ELISA and functional immune assays to study this process.
What is the difference between M-CSF and GM-CSF?
M-CSF (CSF1) and GM-CSF (CSF2) are distinct colony-stimulating factors with different receptor specificities and functions.
Can CRISPR be used to study M-CSF regulation?
Yes, CRISPR knockout, knock-in, point mutation and overexpression models are powerful tools to dissect causal regulators of M-CSF production.
What is the role of THOC5 in M-CSF biology?
THOC5 regulates human osteoclastogenesis, a process dependent on M-CSF signaling.
Conclusion
GO:1901258, positive regulation of macrophage colony-stimulating factor production, is a biologically important process that controls the availability of M-CSF, a cytokine central to monocyte/macrophage biology, osteoclastogenesis and immune responses. Its dysregulation has been linked to myocardial injury, bone disorders and ovarian dysfunction. Understanding the genes and mechanisms that positively regulate M-CSF production requires robust experimental models, and CRISPR-based approaches offer precise tools for causal interrogation. By combining knockout, point-mutation, knock-in and overexpression strategies with functional readouts such as ELISA and RNA-seq, researchers can map the regulatory network of M-CSF production and identify therapeutic targets. EDITGENE provides end-to-end CRISPR services to accelerate this research.
References
- 1. Fan Q et al.. 2019. Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.. Circulation 139(5):663-678 PMID: 30586706
- 2. Mun SH et al.. 2022. THOC5 regulates human osteoclastogenesis.. Eur J Cell Biol 101(3):151248 PMID: 35688054
- 3. Moore RN et al.. 1989. Neurotensin regulation of macrophage colony-stimulating factor-stimulated in vitro myelopoiesis.. J Immunol 142(8):2689-94 PMID: 2784814
- 4. Xu S et al.. 2016. Role of macrophage colony-stimulating factor (M-CSF) in human granulosa cells.. Gynecol Endocrinol 32(12):1005-1008 PMID: 27791429
- 5. Seledtsov VI et al.. 2019. Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis.. Hum Vaccin Immunother 15(12):2903-2909 PMID: 31063025
- 6. Imai T et al.. 1999. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.. Int Immunol 11(1):81-8 PMID: 10050676
- 7. Rodrigues PF et al.. 2023. pDC-like cells are pre-DC2 and require KLF4 to control homeostatic CD4 T cells.. Sci Immunol 8(80):eadd4132 PMID: 36827419
- 8. Takahashi A et al.. 1995. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2.. Blood 86(2):607-16 PMID: 7605990
